Skip to main content
Premium Trial:

Request an Annual Quote

Althea Technologies Granted Patent for Gene Expression Profiling Technology

NEW YORK Sept. 15 (GenomeWeb News) – Althea Technologies of San Diego said today it has been granted a US patent covering its “eXpress” PCR-based gene expression profiling technology.

The patent, No. 6,618,679, is entitled “Methods for Analysis of Gene Expression,” was granted Sept, 9. It covers not only methods, but also kits to enable gene expression profiling, as well as collection of gene expression data and relational data analysis. The methods, according to the patent “are highly highly sensitive; have a wide dynamic range; are rapid and inexpensive; have a high throughput; and allow the simultaneous differential analysis of a defined set of genes.”

The eXpress technology uses rtPCR to monitor tens to hundreds of genes at a time, the company said, and can be used with as little as several nanograms of total RNA and off-the shelf reagents.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.